Videos

Carol Burke, MD, FACG, FASGE, talks about her phase-3 placebo-controlled trial of Celecoxib in pediatric subjects with familial adenomatous polyposis (FAP) at the 2014 ACG Annual Meeting in Philadelphia, PA.

Carol Burke, MD, FACG, FASGE, discusses pediatric familial adenomatous polyposis (FAP) and colorectal cancer at the 2014 ACG Annual Scientific Meeting in Philadelphia, PA.

Charles Bernstein, MD, FACG, discusses his research on Inflammatory Bowel Disease (IBD) treatment at the 2014 ACG Annual Meeting in Philadelphia, PA.

The days of sitting in front of the television with an Atari controller or driving Mario around on his cart are largely over but even the more interactive video games do not do enough to keep this generation of children healthy.

There are many ways children of all ages can learn to read and gain a love for reading, but some ways have proven more effective over the years for a variety of reasons.

As the number of cases of autism in the country continues to grow, there have been several advances in our understanding of the disease and potential treatment targets, while much more work remains to be done.

When working with young patients diagnosed with difficult diseases it can be a challenge to help them and their families work through the treatment process ahead of them, but it is a process that can be successful as a team.

At a time when testing can be done for any number of pediatric diseases and conditions, there have also been questions raised about the benefits and risks of those tests.

The American Academy of Pediatrics first developed a policy for media in relation to children under the age of 2 back in 1999. Since that time much has changed, including the ways in which media is a integrated into a child's life.

With more personal technology devices available than ever before, the need to monitor and regulate kids' screen time and digital device use can be as important as screening the content they watch on the devices.

In young patients dealing with high blood pressure, the choice of treatment options and success of the treatment depends largely on the patients and their families.

Leila Kheirandish Gozal, MD, MSc, from the University of Chicago, discusses several common pediatric sleep disorders.

From cancers caused by the sun to psoriasis and other skin conditions, pediatric dermatologists must be aware of and ready to manage a wide range of conditions.

Jason Newland, MD, Discusses an antimicrobial stewardship program that looked at length of stay and readmission of patients.

Carl Dieffenbach, MD, discusses the changes in HIV treatments in the 30 years since it started making headlines.

Amesh Adalja, MD, FACP, of the University of Pittsburgh Medical Center, was one of several speakers at IDWeek 2014 in Philadelphia discussing the recent Ebola outbreak in West Africa.

Tina Tan, MD, offers insights on preparations for the approaching cold and flu season, which could be one of the worst in years.

Stephen Gluckman, MD, talks about the challenges facing doctors who treat patients infected with Ebola or Enterovirus D68. He also discusses issues facing clinicians as cold and flu season gets underway.

Joseph R. Volpicelli, MD, PhD, is an associate professor in the Department of Psychiatry at the University of Pennsylvania School of Medicine, and a Senior Scientist at the Penn Center for Studies of Addiction. Tracy Steen, PhD, is Clinical Director at the Charles O'Brien Center for Addiction Treatment, University of Pennysylvania.

David R. Gandara, MD, professor of Medicine, University of California Davis Comprehensive Cancer Center, discusses the initial results of the ongoing MYSTIC trial, which is exploring the combination of durvalumab (Imfinzi) and tremelimumab versus chemotherapy in stage IV lung cancer.